LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (AMEX:SLP), a leading provider of software for pharmaceutical discovery and development, today announced that a top three pharmaceutical company has issued a purchase order to renew their global software license and to convert it from a single-year license to a multi-year license.
